{"type":"rich","version":"1.0","provider_name":"Transistor","provider_url":"https://transistor.fm","author_name":"The Dr Kumar Discovery","title":"Lp(a) Q&A: Testing Kids, The Saturated Fat Debate, and Aspirin Risks","html":"<iframe width=\"100%\" height=\"180\" frameborder=\"no\" scrolling=\"no\" seamless src=\"https://share.transistor.fm/e/208e775a\"></iframe>","width":"100%","height":180,"duration":1108,"description":"Following our deep dive into Lipoprotein(a), Dr. Ravi Kumar answers the most pressing listener questions to help you navigate the complexities of this genetic heart risk. \nIn this Q&A session, we move beyond the basics to address real-world clinical concerns and the future of cardiovascular medicine.\nWe discuss:Testing the Next Generation: Why Lp(a) is essentially stable from age 5 and why testing your children can provide a 40-year head start on prevention.The Saturated Fat Paradox: Analyzing the Delta trials and why replacing saturated fats with carbohydrates might actually increase your Lp(a) levels.Exercise & The \"Table\" Analogy: Why exercise doesn't change the cards you’re dealt (your Lp(a) number), but fundamentally changes the \"table\" you're playing on.The Aspirin Protocol: A look at the Women's Health Study and why low-dose aspirin may specifically benefit those with the high-risk LPA gene variant.SiRNA Breakthroughs: An update on Pelacarsen and Olpasiran—drugs that can slash Lp(a) by 90%—and whether you should wait for them to hit the market.","thumbnail_url":"https://img.transistorcdn.com/1b0HAhl7LyS1JMvttJBUPVo13Xhw89dNIYFNVWa7Un0/rs:fill:0:0:1/w:400/h:400/q:60/mb:500000/aHR0cHM6Ly9pbWct/dXBsb2FkLXByb2R1/Y3Rpb24udHJhbnNp/c3Rvci5mbS83NGVi/ODc5ZmE2MTI0Njdj/NWRjODE2NTkzNTQ0/ZjY0Yi5qcGc.webp","thumbnail_width":300,"thumbnail_height":300}